{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:15:28Z","timestamp":1780974928844,"version":"3.54.1"},"reference-count":21,"publisher":"Galenos Yayinevi","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjod"],"DOI":"10.4274\/tjod.galenos.2024.82610","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T06:59:01Z","timestamp":1718002741000},"page":"118-122","source":"Crossref","is-referenced-by-count":1,"title":["Effects of bazedoxifene on endometriosis in experimental animal models: A systematic review and meta-analysis"],"prefix":"10.4274","volume":"21","author":[{"given":"Reza Hassanzadeh","family":"Makoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Fekri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud Hassanzadeh","family":"Makoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s13669-017-0187-1","article-title":"Endometriosis: Epidemiology, Diagnosis and Clinical Management","volume":"6","author":"Parasar","year":"2017","unstructured":"1. Parasar P, Ozcan P, Terry KL. Endometriosis: Epidemiology, Diagnosis and Clinical Management. Curr Obstet Gynecol Rep 2017;6:34-41.","journal-title":"Curr Obstet Gynecol Rep"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis is a chronic systemic disease: clinical challenges and novel innovations","volume":"397","author":"Taylor","year":"2021","unstructured":"2. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. The Lancet 2021;397:839-52.","journal-title":"The Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.3390\/biomedicines11113015","article-title":"Diagnosis of Endometriosis Based on Comorbidities: A Machine Learning Approach","volume":"11","author":"Tore","year":"2023","unstructured":"3. Tore U, Abilgazym A, Asunsolo-del-Barco A, Terzic M, Yemenkhan Y, Zollanvari A, et al. Diagnosis of Endometriosis Based on Comorbidities: A Machine Learning Approach. Biomedicines 2023;11:3015.","journal-title":"Biomedicines"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12958-023-01156-9","article-title":"Evaluating the risk of endometriosis based on patients' self-assessment questionnaires","volume":"21","author":"Zieli\u0144ski","year":"2023","unstructured":"4. Zieli\u0144ski K, Drabczyk D, Kunicki M, Drzyzga D, Kloska A, Rumi\u0144ski J. Evaluating the risk of endometriosis based on patients' self-assessment questionnaires. Reprod Biol Endocrinol 2023;21:102.","journal-title":"Reprod Biol Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.cell.2021.04.041","article-title":"Endometriosis: Etiology, pathobiology, and therapeutic prospects","volume":"184","author":"PTK","year":"2021","unstructured":"5. Saunders PTK, Horne AW. Endometriosis: Etiology, pathobiology, and therapeutic prospects. Cell 2021;184:2807-24.","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1573404813666170621080058","article-title":"Steroid Hormones and Endometriosis","volume":"14","author":"Yland","year":"2018","unstructured":"6. Yland J, Mathyk B, Young LS. Steroid Hormones and Endometriosis. Current Women's Health Rev 2018;14:117-26.","journal-title":"Current Women s Health Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1199010","DOI":"10.3389\/fphar.2023.1199010","article-title":"Research advances in drug therapy of endometriosis","volume":"14","author":"Shi","year":"2023","unstructured":"7. Shi J, Tan X, Feng G, Zhuo Y, Jiang Z, Banda S, et al. Research advances in drug therapy of endometriosis. Front Pharmacol 2023;14:1199010.","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/GRF.0000000000000292","article-title":"Medical Management of Endometriosis","volume":"60","author":"Rafique","year":"2017","unstructured":"8. Rafique S, Decherney AH. Medical Management of Endometriosis. Clin Obstet Gynecol 2017;60:485-96.","journal-title":"Clin Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11154-021-09666-w","article-title":"Hormonal treatments for endometriosis: The endocrine background","volume":"23","author":"Vannuccini","year":"2022","unstructured":"9. Vannuccini S, Clemenza S, Rossi M, Petraglia F. Hormonal treatments for endometriosis: The endocrine background. Rev Endocr Metab Disord 2022;23:333-55.","journal-title":"Rev Endocr Metab Disord"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1358\/dot.2015.51.2.2281023","article-title":"Bazedoxifene\/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women","volume":"51","author":"Palacios","year":"2015","unstructured":"10. Palacios S, Mej\u00eda R\u00edos A. Bazedoxifene\/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women. Drugs Today (Barc) 2015;51:107-16.","journal-title":"Drugs Today (Barc)"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Martinkovich S, Shah D, Planey SL, Arnott JA. Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin Interv Aging 2014;9:1437-52.","DOI":"10.2147\/CIA.S66690"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2217\/17455057.4.4.319","article-title":"Bazedoxifene: A Selective Estrogen-Receptor Modulator","volume":"4","author":"Mitwally","year":"2008","unstructured":"12. Mitwally MF. Bazedoxifene: A Selective Estrogen-Receptor Modulator. Women's Health 2008;4:319-26.","journal-title":"Women s Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","article-title":"Pooling of animal experimental data reveals influence of study design and publication bias","volume":"35","author":"Macleod","year":"2004","unstructured":"13. Macleod MR, O'Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004;35:1203-8.","journal-title":"Stroke"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1210\/en.2010-1010","article-title":"Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model","volume":"152","author":"J Jr","year":"2011","unstructured":"14. Kulak J Jr, Fischer C, Komm B, Taylor HS. Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology 2011;152:3226-32.","journal-title":"Endocrinology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1095\/biolreprod.113.114165","article-title":"Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model","volume":"90","author":"Naqvi","year":"2014","unstructured":"15. Naqvi H, Sakr S, Presti T, Krikun G, Komm B, Taylor HS. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model. Biol Reprod 2014;90:121.","journal-title":"Biol Reprod"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1210\/en.2013-1977","article-title":"Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment","volume":"155","author":"Sakr","year":"2014","unstructured":"16. Sakr S, Naqvi H, Komm B, Taylor HS. Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment. Endocrinology 2014;155:1489-97.","journal-title":"Endocrinology"},{"key":"ref16","unstructured":"17. Lyu H, Liu Y, Dang Q, Chen H, Chen R. [Effect of bazedoxifene on endometriosis in a rat model]. Zhonghua Fu Chan Ke Za Zhi 2015;50:291-5."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12978-018-0506-7","article-title":"A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update","volume":"15","author":"Dai","year":"2018","unstructured":"18. Dai Y, Li X, Shi J, Leng J. A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update. Reproductive Health 2018;15:82.","journal-title":"Reproductive Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.4314\/tjpr.v18i9.2","article-title":"Effect of bazedoxifene on expressions of VEGF, VEGFR2, COX-2 and inflammatory factors in a rat endometriosis model","volume":"18","author":"Hou","year":"2021","unstructured":"19. Hou R, Xu H, Li H. Effect of bazedoxifene on expressions of VEGF, VEGFR2, COX-2 and inflammatory factors in a rat endometriosis model. Trop J of Pharm Res 2021;18:1799-804.","journal-title":"Trop J of Pharm Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/AOG.0000000000002739","article-title":"Bazedoxifene-Conjugated Estrogens for Treating Endometriosis","volume":"132","author":"Flores","year":"2018","unstructured":"20. Flores VA, Stachenfeld NS, Taylor HS. Bazedoxifene-Conjugated Estrogens for Treating Endometriosis. Obstet Gynecol 2018;132:475-7.","journal-title":"Obstet Gynecol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/ccr3.1501","article-title":"Bazedoxifene\/conjugated estrogens in combination with leuprolide for the treatment of endometriosis","volume":"6","author":"Hill","year":"2018","unstructured":"21. Hill AM, Lessey B, Flores VA, Taylor HS. Bazedoxifene\/conjugated estrogens in combination with leuprolide for the treatment of endometriosis. Clin Case Rep 2018;6:990-4.","journal-title":"Clin Case Rep"}],"container-title":["Journal of Turkish Society of Obstetric and Gynecology"],"original-title":[],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T06:30:16Z","timestamp":1718173816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tjoddergisi.org\/articles\/effects-of-bazedoxifene-on-endometriosis-in-experimental-animal-models-a-systematic-review-and-meta-analysis\/doi\/tjod.galenos.2024.82610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,10]]}},"URL":"https:\/\/doi.org\/10.4274\/tjod.galenos.2024.82610","relation":{},"ISSN":["1307-699X","2149-9330"],"issn-type":[{"value":"1307-699X","type":"print"},{"value":"2149-9330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]}}}